The global export market for extracts of glands for therapeutic use shows interesting trends as of 2023. The United Kingdom leads significantly with exports valued at $161.6 million, reflecting a strong year-on-year growth of 27.91%. The United States follows, albeit with more modest growth at 1.27%. While countries like Denmark and China have shown slight increases, Japan, Germany, and other markets such as Spain and Canada have witnessed declines. In contrast, emerging players like Colombia and Madagascar demonstrate substantial growth percentages, with respective year-on-year increases of 18.86% and 91.59%, highlighting potential opportunities in these markets.
Future trends to watch include the potential expansion of exports from emerging markets, as well as continued leadership from the United Kingdom. Innovations in therapeutic applications and a possible increase in global demand may further enhance these exports. Monitoring geopolitical factors, regulatory changes, and advancements in gland extract technologies might also offer insights into how countries could adjust strategies to optimize their positions in this niche market.
Top countries in Export of Extracts of Glands for Therapeutic Use by Country
| # | 10 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United Kingdom | 161,600,000 | 2023 | +4.77% | +27.91% | View data |
| 2 | 2 United States | 56,151,000 | 2023 | +1.23% | +1.27% | View data |
| 3 | 3 Denmark | 34,290,000 | 2023 | +2.89% | +0.69% | View data |
| 4 | 4 Japan | 33,411,000 | 2023 | +3.11% | -0.49% | View data |
| 5 | 5 Australia | 23,082,000 | 2023 | +5.23% | +4.16% | View data |
| 6 | 6 China | 15,991,000 | 2023 | +0.45% | +1.6% | View data |
| 7 | 7 Italy | 15,503,000 | 2023 | -2.73% | +0.66% | View data |
| 8 | 8 Czech Republic | 11,194,000 | 2023 | +6.99% | +15.81% | View data |
| 9 | 9 Belgium | 9,957,400 | 2023 | +3.37% | +2.81% | View data |
| 10 | 10 Spain | 7,891,900 | 2023 | +1.74% | -3.51% | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...